164 related articles for article (PubMed ID: 20108343)
1. Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex.
Pressey JG; Wright JM; Geller JI; Joseph DB; Pressey CS; Kelly DR
Pediatr Blood Cancer; 2010 Jul; 54(7):1035-7. PubMed ID: 20108343
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus and tuberous sclerosis-associated renal angiomyolipomas.
Krischock L; Beach R; Taylor J
Arch Dis Child; 2010 May; 95(5):391-2. PubMed ID: 20457704
[TBL] [Abstract][Full Text] [Related]
3. Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex.
Wienecke R; Fackler I; Linsenmaier U; Mayer K; Licht T; Kretzler M
Am J Kidney Dis; 2006 Sep; 48(3):e27-9. PubMed ID: 16931204
[TBL] [Abstract][Full Text] [Related]
4. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.
Al-Saleem T; Wessner LL; Scheithauer BW; Patterson K; Roach ES; Dreyer SJ; Fujikawa K; Bjornsson J; Bernstein J; Henske EP
Cancer; 1998 Nov; 83(10):2208-16. PubMed ID: 9827727
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex.
Tarasewicz A; Debska-Slizień A; Konopa J; Zdrojewski Z; Rutkowski B
Transplant Proc; 2009 Nov; 41(9):3677-82. PubMed ID: 19917366
[TBL] [Abstract][Full Text] [Related]
6. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors.
Kenerson HL; Aicher LD; True LD; Yeung RS
Cancer Res; 2002 Oct; 62(20):5645-50. PubMed ID: 12384518
[TBL] [Abstract][Full Text] [Related]
7. Two different types of infantile renal cell carcinomas associated with tuberous sclerosis.
Kubo M; Iwashita K; Oyachi N; Oyama T; Yamamoto T
J Pediatr Surg; 2011 Oct; 46(10):E37-41. PubMed ID: 22008361
[TBL] [Abstract][Full Text] [Related]
8. [A case of renal cell carcinoma associated with tuberous sclerosis].
Kakimoto K; Mori N; Tei N; Hara T; Koide T
Hinyokika Kiyo; 1999 May; 45(5):335-8. PubMed ID: 10410316
[TBL] [Abstract][Full Text] [Related]
9. A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.
Tyburczy ME; Jozwiak S; Malinowska IA; Chekaluk Y; Pugh TJ; Wu CL; Nussbaum RL; Seepo S; Dzik T; Kotulska K; Kwiatkowski DJ
Hum Mol Genet; 2015 Apr; 24(7):1836-42. PubMed ID: 25432535
[TBL] [Abstract][Full Text] [Related]
10. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
Hofbauer GF; Marcollo-Pini A; Corsenca A; Kistler AD; French LE; Wüthrich RP; Serra AL
Br J Dermatol; 2008 Aug; 159(2):473-5. PubMed ID: 18547304
[TBL] [Abstract][Full Text] [Related]
11. Developing multiple lung nodules in a renal transplant recipient with tuberous sclerosis who had undergone bilateral nephrectomy due to renal cell carcinomas.
Saito M; Yuasa T; Satoh S; Nanjo H; Tsuchiya N; Habuchi T
Int J Urol; 2008 Mar; 15(3):257-8. PubMed ID: 18304223
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient.
Micozkadioglu H; Koc Z; Ozelsancak R; Yildiz I
Ren Fail; 2010; 32(10):1233-6. PubMed ID: 20954988
[TBL] [Abstract][Full Text] [Related]
13. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment.
Jozwiak J; Jozwiak S; Oldak M
Med Res Rev; 2006 Mar; 26(2):160-80. PubMed ID: 16329102
[TBL] [Abstract][Full Text] [Related]
14. A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma.
Wilson C; Idziaszczyk S; Parry L; Guy C; Griffiths DF; Lazda E; Bayne RA; Smith AJ; Sampson JR; Cheadle JP
Hum Mol Genet; 2005 Jul; 14(13):1839-50. PubMed ID: 15888477
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors.
Lam C; Bouffet E; Tabori U; Mabbott D; Taylor M; Bartels U
Pediatr Blood Cancer; 2010 Mar; 54(3):476-9. PubMed ID: 19856393
[TBL] [Abstract][Full Text] [Related]
16. Optic nerve tumor in tuberous sclerosis complex is not responsive to sirolimus.
Sparagana SP; Wilkes DC; Thompson CE; Bowers DC
Pediatr Neurol; 2010 Jun; 42(6):443-6. PubMed ID: 20472200
[TBL] [Abstract][Full Text] [Related]
17. Huge renal angiomyolipomas in tuberous sclerosis complex.
Chan SY; Chan WK
Nephrology (Carlton); 2005 Aug; 10(4):382-6. PubMed ID: 16109086
[TBL] [Abstract][Full Text] [Related]
18. Bilateral chromophobe cell renal carcinoma in tuberous sclerosis complex.
Hidai H; Chiba T; Takagi Y; Taki A; Nagashima Y; Kuroko K
Int J Urol; 1997 Jan; 4(1):86-9. PubMed ID: 9179674
[TBL] [Abstract][Full Text] [Related]
19. [Recent advance in tuberous sclerosis-related genes and their expression].
Liu J; Piao YS; Lu DH
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):210-2. PubMed ID: 20450774
[No Abstract] [Full Text] [Related]
20. Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex.
Peces R; Peces C; Cuesta-López E; Pérez-Dueñas V; Vega-Cabrera C; Azorín S; Selgas R
Nephrol Dial Transplant; 2010 Nov; 25(11):3787-91. PubMed ID: 20663789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]